Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

36.4%

4 terminated out of 11 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results50% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 2 (2)
P 3 (1)
P 4 (1)

Trial Status

Completed4
Terminated4
Enrolling By Invitation1
Recruiting1
Unknown1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (11)

Research Network

Activity Timeline